Wockhardt Share Price
Small Cap | Pharmaceuticals and health care | NSE: WOCKPHARMA | BSE: 532300
₹1,315.65 
-66.85 (-4.84 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 1,399.95
High (₹) 1,404.75
Low (₹) 1,313.40
Prev. Close (₹) 1,382.50
Volume 17,280
VWAP (₹) 1,344.60
ROCE (%) -2.07
Industry P/E 43.99
TTM P/E -111.97
P/B Ratio 5.54
Market Cap (₹) Cr.21,392.04
Dividend Yield (%)--
EPS (₹) -32.05
ROE-13.48%
Sales Growth (%) 5.55
Profit Growth (%)-23.99
Day Range
1,404.751,404.75
52 Week Range
489.201,678.60
Historical Returns
Returns (6M)
24.29 %
Returns (1Y)
131.71 %
Returns (3Y)
285.21 %
Returns (5Y)
320.7 %
Returns (6M)
24.29 %
Returns (1Y)
131.71 %
Returns (3Y)
285.21 %
Returns (5Y)
320.7 %
SWOT Analysis
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
BEARISHRSI 36.88
MFI 32.35
ATR 80.68
Commodity Channel Index -70.64
ROC125 29.31
ROC21 -4.36
Williams %R -97.29
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,375.80 | 1,435.95 | 1,467.15 | 1,344.60 | 1,284.45 | 1,253.25 | 1,193.10 |
| Week Ago | 1,419.36 | 1,455.98 | 1,481.96 | 1,393.38 | 1,356.76 | 1,330.78 | 1,294.16 |
| Month Ago | 1,380.36 | 1,420.38 | 1,447.56 | 1,353.18 | 1,313.16 | 1,285.98 | 1,245.96 |
EMA & SMA
1315.65
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
16
5 Day 1381.72
9 Day 1410.95
10 Day 1433.82
12 Day 1491.73
14 Day 1497.36
20 Day 1438.37
26 Day 1428.44
50 Day 1432.74
100 Day 1301.32
200 Day 1050.62
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| NEOMILE CORPORATE ADVISORY PRIVATE LIMITED | bulk | Sell | 07 Dec, 2022 | ₹225.00 | 2,600 | BSE |
| KIRTAN MANEKLAL RUPARELIYA | bulk | Sell | 07 Dec, 2022 | ₹225.00 | 707 | BSE |
| HUMUZA CONSULTANTS | bulk | Sell | 07 Dec, 2022 | ₹225.00 | 25,00,000 | BSE |
| NEOMILE CORPORATE ADVISORY PRIVATE LIMITED | bulk | Buy | 07 Dec, 2022 | ₹225.00 | 15,32,498 | BSE |
| KIRTAN MANEKLAL RUPARELIYA | bulk | Buy | 07 Dec, 2022 | ₹225.00 | 7,25,000 | BSE |
| KIRTAN MANEKLAL RUPARELIYA (HUF) | bulk | Buy | 27 Aug, 2021 | ₹405.66 | 5,98,252 | BSE |
| KIRTAN MANEKLAL RUPARELIYA (HUF) | bulk | Sell | 26 Aug, 2021 | ₹447.02 | 9,386 | BSE |
| KIRTAN MANEKLAL RUPARELIYA (HUF) | bulk | Buy | 26 Aug, 2021 | ₹440.01 | 6,03,850 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 27 Dec, 2024 | Muayyad Khorakiwala | Acquisition | ₹ | 1,800 | BSE |
| 11 Mar, 2022 | Themisto Trustee Company Private Limited | Pledge | ₹313.15 | 17,40,000 | BSE |
| 01 Mar, 2022 | Themisto Trustee Company Private Limited | Pledge | ₹340.3288314176245210727969349 | 52,20,000 | BSE |
| 28 Dec, 2021 | Themisto Trustee Company Private Limited | Pledge | ₹393.95 | 19,00,000 | BSE |
| 02 Dec, 2021 | Themisto Trustee Company Private Limited | Pledge | ₹435.55 | 4,00,000 | BSE |
| 26 Oct, 2021 | Themisto Trustee Company Private Limited | Pledge | ₹462.30 | 13,50,000 | BSE |
| 11 Oct, 2021 | Themisto Trustee Company Private Limited | Revoke | ₹480.30 | 98,000 | BSE |
| 03 Sept, 2021 | Themisto Trustee Company Private Limited | Pledge | ₹420.20 | 1,90,000 | BSE |
| 03 Sept, 2021 | Themisto Trustee Company Private Limited | Pledge | ₹403.0758064516129032258064516 | 12,40,000 | BSE |
| 01 Sept, 2021 | Ananke Trustee Company Private Limited | Disposal | ₹399.11148 | 3,00,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 06 Jan, 2022 | Rights issue of equity shares of Rs. 5/- each in the ratio of 3:10 @ premium of Rs. 220/-. | 08 Mar, 2022 | 09 Mar, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 14 Feb, 2025 | BSE India | We wish to inform you that the Share allotment Committee of the Board of Directors of the Company has allotted 13,250 equity shares of face value Rs. 5/- each on 14th February, 2025 |
| 14 Feb, 2025 | BSE India | We wish to inform you that the Share allotment Committee of the Board of Directors of the Company has allotted 13,250 equity shares of face value Rs. 5/- each on 14th February, 2025 |
| 14 Feb, 2025 | NSE India | Wockhardt Limited has informed the Exchange regarding Allotment of Securities |
| 14 Feb, 2025 | NSE India | Wockhardt Limited has informed the Exchange regarding allotment of 13,250 equity shares of face value of Rs.5/- each on 14th February, 2025, pursuant to exercise of stock options under Employee Stock Options Scheme - 2011 of the Company |
| 07 Feb, 2025 | BSE India | We are submitting herewith the Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024. |
| 07 Feb, 2025 | NSE India | Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31st December, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated 2nd January, 2025, we are submitting herewith the Integrated Filing (Financial) for the quarter and nine-months ended 31st December, 2024 |
| 07 Feb, 2025 | NSE India | Wockhardt Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
| 07 Feb, 2025 | BSE India | Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we hereby confirm that there has been no deviation in the utilisation of the issue proceeds from the object as stated in the Placement Documents dated 26th March 2024 and 11th November 2024 and accordingly, the Statements of Deviations in the prescribed format confirming Nil deviation duly reviewed by the Audit Committee are attached |
| 07 Feb, 2025 | NSE India | Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 173A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed Monitoring Agency Reports towards utilization of proceeds of following Qualified Institutions Placements ( QIPs ) for the quarter ended 31st December, 2024, issued by CRISIL Ratings Limited, duly reviewed and taken on record by the Board of Directors & Audit Committee of the Company. A. Qualified Institutional Placement of ₹480.04 Crore vide Placement Document dated 26thMarch, 2024 (Annexure 1) B. Qualified Institutional Placement of approx. ₹1,000 Crore vide Placement Document dated 11th November, 2024 (Annexure 2) Further, we hereby confirm that there has been no deviation in the utilization of Issue proceeds from the objects as stated in the Placement Documents. Kindly take the above information on record. |
| 07 Feb, 2025 | BSE India | Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 173(A) of the SEBI ( Issue of Capital and Disclosure Requirements) Regulations, 2018, please find attached Monitoring Agency Reports towards utilisation of proceeds of following Qualified institutions Placements (\QIPs\) for the quarter ended 31st December, 2024 issued by CRISIL Rating Limited, duly reviewed and taken on record by Board of Directors & Audit Committee of the Company\r\n1. QIP of Rs. 480.04 crore vide Placement Document dated 26.03.2024 (Annexure 1)\r\n2. QIP of Approx. Rs. 1000 crore vide Placement Document dated 11.11.2024 (Annexure 2)\r\n |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 04 Feb, 2025 | 07 Feb, 2025 |
| Quarterly Results | -- | 09 Nov, 2024 | 13 Nov, 2024 |
| Quarterly Results | -- | 06 Aug, 2024 | 09 Aug, 2024 |
| Audited Results | -- | 22 May, 2024 | 28 May, 2024 |
| Others | Inter alia, to consider and determine the issue price of Equity Shares to be issued pursuant to the Issue, including any discount, not more than 5%, on the floor price. | 22 Mar, 2024 | 26 Mar, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 14 Feb, 2024 |
| Quarterly Results | -- | 07 Nov, 2023 | 14 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 14 Aug, 2023 |
| Audited Results & Others | To consider : Raising of funds by various method as may be permitted under applicable law, subject to consent of shareholder at the ensuing Annual General Meeting and such approvals. | 22 May, 2023 | 26 May, 2023 |
| Quarterly Results | -- | 06 Feb, 2023 | 13 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Nov, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Wockhardt
Wockhardt is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1154.00 Cr. and Equity Capital is Rs. 77.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Wockhardt Group
Founded
1999
Managing Director
Dr. Murtaza Khorakiwala
NSE Symbol
WOCKPHARMA
Wockhardt Management
| Name | Designation |
|---|---|
| Dr. Habil Khorakiwala | Founder Chairman |
| Dr. Murtaza Khorakiwala | Managing Director |
| Dr. Huzaifa Khorakiwala | Executive Director |
| Ms. Zahabiya Khorakiwala | Non Executive Director |
| Mrs. Tasneem Mehta | Independent Director |
| Mr. Vinesh Kumar Jairath | Independent Director |
| Mr. Akhilesh Gupta | Independent Director |
| Ms. Amelia Fernandes | Independent Director |
| Mr. Ahmad Javed | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Wockhardt
What is the share price of Wockhardt?
The share price of Wockhardt on 21 Feb, 2025 is ₹ 1,315.65.
What is 52W high and 52W low share price of Wockhardt?
The highest and lowest 52W share prices of Wockhardt are ₹ 1536.400 and ₹ 402.850
What is the market cap of Wockhardt?
The market capitalization of Wockhardt as of 21 Feb, 2025 is ₹ 21,392.04 Crores
What is the P/E ratio of Wockhardt?
The current P/E ratio of Wockhardt as of 21 Feb, 2025 is 43.99
What is the PB ratio of Wockhardt?
The PB ratio of Wockhardt as of 21 Feb, 2025 is 5.54
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)